Clinical Trials Logo
  1. Home
  2. Anemia
  3. NCT02448745
  4. Details
NCT02448745 Clinical Trial

Liberia Insecticide Treated Durable Wall Linings Study: Protocol for a Cluster Randomised Trial (DL)

Anemia Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT02448745
Other study ID # LiberiaDL
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 1, 2014
Est. completion date April 1, 2017

Study information
Verified date April 2018
Source The Mentor Initiative
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A cluster-randomized control trial will study the effect of insecticide-treated wall lining on malaria transmission in Bomi County, Liberia. Half of the villages enrolled in the study will receive insecticide-treated wall lining covering their walls and ceilings in addition to long-lasting insecticidal nets, while the other half will be protected by existing long-lasting insecticidal nets.

Description:

Long-lasting insecticidal nets (LLINs) are the established vector control product for malaria control. In Bomi County Liberia, LLINs have been distributed but malaria prevalence in children under 5 remains high, with prevalence in study villages found to be 42% in April 2014. The major malaria vector species are resistant to pyrethroid insecticides approved for use in LLINs, and new control measures with non-pyrethroid active ingredients may protect the population.

Recruitment information / eligibility
Status Completed
Enrollment 6317
Est. completion date April 1, 2017
Est. primary completion date June 1, 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 2 Months to 59 Months
Eligibility Inclusion Criteria:

- Child resides in village

- Child presents with parent or guardian

Exclusion Criteria:

- Child or guardian has history of Ebola exposure

- Child has 3 symptoms of Ebola

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• Insecticide treated wall lining
Polypropylene non-woven fabric.

Locations
Country Name City State
Liberia Bomi County Health Team Tubmanburg Bomi County

Sponsors (2)
Lead Sponsor Collaborator
The Mentor Initiative Ministry of Health, Liberia

Country where clinical trial is conducted

Liberia, 

Outcome
Type Measure Description Time frame Safety issue
Primary Malaria Prevalence Tested by mRDT and PCR 6 months
Secondary Hemoglobin Hemoglobin measured by Hemocue 301 6 months
Secondary Fever Number of participants with Fever, defined as tympanic temperature above 37.5C 6 months
Secondary Mosquito biting rate. Mosquitoes trapped indoors and outdoors using light traps and exit traps. 2 months
See also
  Status Clinical Trial Phase
Terminated NCT00801931 - Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders Phase 1/Phase 2
Completed NCT02948283 - Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia Phase 1
Completed NCT03341338 - Genes-in-Action - Hepcidin Regulation of Iron Supplementation
Completed NCT00060398 - Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer Phase 3
Recruiting NCT05384691 - Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions Phase 2
Active, not recruiting NCT02101944 - Wild-Type Reovirus in Combination With Carfilzomib and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma Phase 1
Not yet recruiting NCT06309641 - Methemoglobinemia Following Intravenous Iron Treatment
Completed NCT02930850 - Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation N/A
Completed NCT02912494 - A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD) Phase 3
Completed NCT02912533 - A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD) Phase 3
Completed NCT03822884 - Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers Phase 1
Completed NCT02888171 - Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency N/A
Completed NCT02384122 - Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias Phase 3
Completed NCT02603250 - Evaluation of Hemoglobin Measurement Tools for Child Anemia Screening in Rwanda N/A
Completed NCT02176759 - Iron Absorption From Rice Fortified With Ferric Pyrophosphate N/A
Withdrawn NCT01934842 - A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate N/A
Completed NCT02310113 - Transfusion and Skeletal Muscle Tissue Oxygenation N/A
Completed NCT01922479 - Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure Phase 4
Completed NCT01693029 - Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa Phase 3
Completed NCT01432717 - Study of ACE-536 in Healthy Postmenopausal Women Phase 1

External Links